How to report a possible side effect?
To help us process your information quickly and effectively, please report as much relevant information as possible. At a minimum you will need to provide the following:
- The initials of the person who experienced the possible side effect and/or other identifiers, such as gender, date of birth
- The contact information of the person reporting the issue
- A description of the possible side effect, such as the signs and symptoms experienced, date the possible side effect started and the result of the possible side effect
- The name of the GSK product
Our Privacy Notice outlines how we handle the processing of personal information when dealing with your enquiry, complaint or adverse event report.
For contact details and to report a possible side effect, please select your home market from the list below.
Select a region and market
Algeria
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +21321989630
Email address: pharmacovigilance.na@gsk.com
Bahrain
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: gulf.safety@gsk.com
Benin
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Burundi
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Cameroon
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Central African Republic
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Chad
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Congo Brazzaville
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Cote d’Ivoire
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Democratic Republic of the Congo
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Djibouti
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Egypt
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +20 (2) 26185150
Email address: ae.egypt@gsk.com
Ethiopia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Gabon
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Ghana
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Guinea
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Gulf & Near East
Telephone number:
Gulf Tel: +97144037100
Near East: +9611449646
Email address:
Gulf: gulf.safety@gsk.com
Near East: NE.Safety@gsk.com
Iraq
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Israel
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +97239297100
Email address: il.safety@gsk.com
Jordan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Kazakhstan
To report a possible side effect:
Telephone number: +7 727 313 1207
Email address: kz.safety@gsk.com
Kenya
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Kuwait
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: gulf.safety@gsk.com
Lebanon
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Liberia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Libya
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Mali
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Morroco
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +212 5 22 48 00 02
Email address: pharmacovigilance.na@gsk.com
Niger
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Nigeria
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Oman
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: gulf.safety@gsk.com
Qatar
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: gulf.safety@gsk.com
Rwanda
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Senegal
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Sierra Leone
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
South Africa
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +27 10 300 1000
Email address: aereporting.za@gsk.com
Southern Africa
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Sudan North
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email Address: pm.Safety@gsk.com
Tanzania
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Togo
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Tunisia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Uganda
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
United Arab Emirates
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: gulf.safety@gsk.com
Western & Central Africa
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Yemen
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Zambia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Zimbabwe
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Argentina
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: 0800 220 4752
Email address: bua-farmacovigilancia-rx@gsk.com
Bolivia and Paraguay
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +541147258900
Email address: Bua-Farmacovigilancia-Rx@gsk.com
Brazil
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +08007012233
Email address: farmacovigilancia@gsk.com
Canada
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +18003877374
Email address: drugsurv.a.ca@gsk.com
Chile
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +56223829000
Email address: farmacovigilancia.chile@gsk.com
Costa Rica
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +(506)40554242
Email address: fv.aecaricam@gsk.com
Dominican-Republic
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +18299566335
Email address: fv.aecaricam@gsk.com
Ecuador
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +59322994700 Ext. 5
Email address: farmacovigilancia.ecuador@gsk.com
El-Salvador
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +(503)21367801
Email address: fv.aecaricam@gsk.com
Guatemala
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +(502)23761930
Email address: fv.aecaricam@gsk.com
Honduras
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +(504)25401638
Email address: fv.aecaricam@gsk.com
Jamaica
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +18766302074
Email address: fv.aecaricam@gsk.com
Mexico
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number (toll free): 800 276 9263
Email address: farmacovigilancia.mx@gsk.com
Nicaragua
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +(505) 67795256
Email address: fv.aecaricam@gsk.com
Panama
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +(507)8336768
Email address: fv.aecaricam@gsk.com
Peru
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +5112119700
Email address: farmacovigilancia.peru@gsk.com
Trinidad and Tobago
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +18682245759
Email address: fv.aecaricam@gsk.com
Uruguay
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +59824198333
Email address: uy.farmacovigilancia@gsk.com
USA
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Tel: +1 888 825 5249
Email: WW.GSKAEReportingUS@gsk.com
Venezuela
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +58 (0800) 8987987
Email address: ven.farmacovigilancia@gsk.com
Afghanistan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.Safety@gsk.com
Armenia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +74957778900
Email address: BY.safety@gsk.com
Australia
To report a possible side effect:
Online: Adverse event reporting form
Tel: 1800 033 109 or +61 3 9413 7200
Azerbaijan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Bangladesh
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: oax70065@gsk.com
Hong Kong and Macau
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +85231898989 (Hong Kong) or +853 28715569 (Macau)
Email address: HKAdverseEvent@gsk.com
India
To report a possible side effect:
Toll free number: +1800222203
Telephone number: +912224959595
Mobile number: +91-8657549542
Indonesia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +622125532350
Email address: yqq68540@gsk.com
Kyrgyzstan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +74957778900
Email address: ru.safety@gsk.com
Laos
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Malaysia & Brunei
Online: Patient safety reporting form (Preferred method of contact)
Email address: drugsafetyinfo.my@gsk.com
Mongolia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Myanmar
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
New Zealand
To report a possible side effect:
Online: Adverse event reporting form
Tel: 0800 808 500 or +64 9 367 2900
Pakistan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +9221111475725 EXT 7 OR 8
Email address: pk_pharmasafety@gsk.com
Philippines
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +632 8892 0761
Email address: ph.safety@gsk.com
Singapore
Online: Patient safety reporting form (Preferred method of contact)
Email address: sg.drugsafety@gsk.com
Sri-Lanka
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Taiwan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +886223126836
Email address: oax40892@gsk.com
Tajikistan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Thailand
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: safety_th@gsk.com
Turkmenistan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Uzbekistan
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Albania
Telephone number:
Email address:
Website address:
Kosovo
Telephone number:
Austria
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +431970750
Email address: arzneimittelsicherheit@gsk.com
Belarus
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +74957778900
Email address: by.safety@gsk.com
Denmark
Online: Patient safety reporting form
Telephone number: +4536359100
Email address: dk-safety@gsk.com
Estonia
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +3728002640
Email address: estoniansafety@gsk.com
Georgia
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Greece
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +302106882100
Email address: gr.pharmacovigilance@gsk.com
Hungary
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +3680088309
Email address: Hungary.PH_Safety@gsk.com
Iceland
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +4536359100
Email address: dk-safety@gsk.com
Ireland
To report a possible side effect:
Online: Patient safety reporting form
Tel: 1800 244 255
Email: Ireland.Drugsurveillance@gsk.com
Italy
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +390457748005
Email address: drugsurveillance-italy@gsk.com
Luxembourg
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +3210855200
Email address: be.medinfo@gsk.com
Moldova
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: pm.safety@gsk.com
Netherlands
To report a possible side effect:
Telephone number: +31332081100
Email address: nl.bijwerking@gsk.com
North Macedonia
Telephone number:
Email address:
Norway
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +4722702000
Email address: no.safety@gsk.com
Poland
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +48225769000
Email address: uyz84328@gsk.com
Portugal
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +351214129500
Email address: LIS.Nucleo-Farmacovigilancia@gsk.com
Russia
To report a possible side effect:
Telephone number: +74957778900
Email address: ru.safety@gsk.com
Sweden
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +4686389300
Email address: safetysweden@gsk.com
Switzerland
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Telephone number: +41318622111
Email address: pv.swiss@gsk.com
Ukraine
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Email address: oax70065@gsk.com
United Kingdom
To report a possible side effect:
Online: Patient safety reporting form (Preferred method of contact)
Tel: 0800 221 441
Email: uksafety@gsk.com
